209 related articles for article (PubMed ID: 19138995)
21. Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models.
Bhat KP; Lantvit D; Christov K; Mehta RG; Moon RC; Pezzuto JM
Cancer Res; 2001 Oct; 61(20):7456-63. PubMed ID: 11606380
[TBL] [Abstract][Full Text] [Related]
22. Gene expression profiling changes induced by a novel Gemini Vitamin D derivative during the progression of breast cancer.
Lee HJ; Liu H; Goodman C; Ji Y; Maehr H; Uskokovic M; Notterman D; Reiss M; Suh N
Biochem Pharmacol; 2006 Jul; 72(3):332-43. PubMed ID: 16737686
[TBL] [Abstract][Full Text] [Related]
23. Effect of prenatal and prepubertal genistein exposure on N-methyl-N-nitrosourea-induced mammary tumorigenesis in female Sprague-Dawley rats.
Pei RJ; Sato M; Yuri T; Danbara N; Nikaido Y; Tsubura A
In Vivo; 2003; 17(4):349-57. PubMed ID: 12929590
[TBL] [Abstract][Full Text] [Related]
24. Mechanisms by which energy restriction inhibits rat mammary carcinogenesis: in vivo effects of corticosterone on cell cycle machinery in mammary carcinomas.
Zhu Z; Jiang W; Thompson HJ
Carcinogenesis; 2003 Jul; 24(7):1225-31. PubMed ID: 12807724
[TBL] [Abstract][Full Text] [Related]
25. Equivalent anticancer activities of dietary vitamin D and calcitriol in an animal model of breast cancer: importance of mammary CYP27B1 for treatment and prevention.
Krishnan AV; Swami S; Feldman D
J Steroid Biochem Mol Biol; 2013 Jul; 136():289-95. PubMed ID: 22939886
[TBL] [Abstract][Full Text] [Related]
26. A novel vitamin D derivative activates bone morphogenetic protein signaling in MCF10 breast epithelial cells.
Lee HJ; Wislocki A; Goodman C; Ji Y; Ge R; Maehr H; Uskokovic M; Reiss M; Suh N
Mol Pharmacol; 2006 Jun; 69(6):1840-8. PubMed ID: 16533909
[TBL] [Abstract][Full Text] [Related]
27. Novel vitamin D(3) analog, 21-(3-methyl-3-hydroxy-butyl)-19-nor D(3), that modulates cell growth, differentiation, apoptosis, cell cycle, and induction of PTEN in leukemic cells.
Hisatake J; O'Kelly J; Uskokovic MR; Tomoyasu S; Koeffler HP
Blood; 2001 Apr; 97(8):2427-33. PubMed ID: 11290607
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and mechanism of action of 1alpha-hydroxy-24-ethyl-cholecalciferol (1alpha[OH]D5) in breast cancer prevention and therapy.
Hussain EA; Mehta RR; Ray R; Das Gupta TK; Mehta RG
Recent Results Cancer Res; 2003; 164():393-411. PubMed ID: 12899538
[TBL] [Abstract][Full Text] [Related]
29. Prevention of N-methyl-N-nitrosourea-induced breast cancer by alpha-fetoprotein (AFP)-derived peptide, a peptide derived from the active site of AFP.
Parikh RR; Gildener-Leapman N; Narendran A; Lin HY; Lemanski N; Bennett JA; Jacobson HI; Andersen TT
Clin Cancer Res; 2005 Dec; 11(23):8512-20. PubMed ID: 16322315
[TBL] [Abstract][Full Text] [Related]
30. Effects of 1,25 dihydroxyvitamin D3 and its analogues on induction of apoptosis in breast cancer cells.
James SY; Mackay AG; Colston KW
J Steroid Biochem Mol Biol; 1996 Jul; 58(4):395-401. PubMed ID: 8903423
[TBL] [Abstract][Full Text] [Related]
31. Mixed tocopherols prevent mammary tumorigenesis by inhibiting estrogen action and activating PPAR-gamma.
Lee HJ; Ju J; Paul S; So JY; DeCastro A; Smolarek A; Lee MJ; Yang CS; Newmark HL; Suh N
Clin Cancer Res; 2009 Jun; 15(12):4242-9. PubMed ID: 19509159
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of Mouse Breast Tumor-Initiating Cells by Calcitriol and Dietary Vitamin D.
Jeong Y; Swami S; Krishnan AV; Williams JD; Martin S; Horst RL; Albertelli MA; Feldman BJ; Feldman D; Diehn M
Mol Cancer Ther; 2015 Aug; 14(8):1951-61. PubMed ID: 25934710
[TBL] [Abstract][Full Text] [Related]
33. The potential therapeutic benefits of vitamin D in the treatment of estrogen receptor positive breast cancer.
Krishnan AV; Swami S; Feldman D
Steroids; 2012 Sep; 77(11):1107-12. PubMed ID: 22801352
[TBL] [Abstract][Full Text] [Related]
34. Antiestrogen potentiation of antiproliferative effects of vitamin D3 analogues in breast cancer cells.
Love-Schimenti CD; Gibson DF; Ratnam AV; Bikle DD
Cancer Res; 1996 Jun; 56(12):2789-94. PubMed ID: 8665515
[TBL] [Abstract][Full Text] [Related]
35. Oral administration of a gemini vitamin D analog, a synthetic triterpenoid and the combination prevents mammary tumorigenesis driven by ErbB2 overexpression.
So JY; Wahler JE; Yoon T; Smolarek AK; Lin Y; Shih WJ; Maehr H; Uskokovic M; Liby KT; Sporn MB; Suh N
Cancer Prev Res (Phila); 2013 Sep; 6(9):959-70. PubMed ID: 23856074
[TBL] [Abstract][Full Text] [Related]
36. Colon cancer and solar ultraviolet B radiation and prevention and treatment of colon cancer in mice with vitamin D and its Gemini analogs.
Spina C; Tangpricha V; Yao M; Zhou W; Wolfe MM; Maehr H; Uskokovic M; Adorini L; Holick MF
J Steroid Biochem Mol Biol; 2005 Oct; 97(1-2):111-20. PubMed ID: 16154354
[TBL] [Abstract][Full Text] [Related]
37. Effect of energy restriction on cell cycle machinery in 1-methyl-1-nitrosourea-induced mammary carcinomas in rats.
Jiang W; Zhu Z; Thompson HJ
Cancer Res; 2003 Mar; 63(6):1228-34. PubMed ID: 12649181
[TBL] [Abstract][Full Text] [Related]
38. Novel Gemini analogs of 1alpha,25-dihydroxyvitamin D(3) with enhanced transcriptional activity.
Weyts FA; Dhawan P; Zhang X; Bishop JE; Uskokovic MR; Ji Y; Studzinski GP; Norman AW; Christakos S
Biochem Pharmacol; 2004 Apr; 67(7):1327-36. PubMed ID: 15013848
[TBL] [Abstract][Full Text] [Related]
39. "Non-hypercalcemic" analogs of 1alpha,25 dihydroxy vitamin D augment the induction of creatine kinase B by estrogen and selective estrogen receptor modulators (SERMS) in osteoblast-like cells and rat skeletal organs.
Somjen D; Waisman A; Weisman Y; Kaye AM
J Steroid Biochem Mol Biol; 2000; 72(1-2):79-88. PubMed ID: 10731641
[TBL] [Abstract][Full Text] [Related]
40. Analogs of 1alpha,25-dihydroxyvitamin D(3) as novel inhibitors of renin biosynthesis.
Qiao G; Kong J; Uskokovic M; Li YC
J Steroid Biochem Mol Biol; 2005 Jun; 96(1):59-66. PubMed ID: 15878826
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
